Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ZKAB001 |
| Trade Name | |
| Synonyms | ZKAB 001|ZKAB-001|Socazolimab|STIA1014|STI-A1014|STI A1014 |
| Drug Descriptions |
ZKAB001 is a monoclonal antibody targeting CD274 (PD-L1), which potentially induces antibody-dependent cell-mediated cytotoxicity (ADCC) and inhibition of tumor growth (PMID: 36469563). |
| DrugClasses | PD-L1/PD-1 antibody 132 |
| CAS Registry Number | 2305043-30-3 |
| NCIT ID | C162504 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Carboplatin + Etoposide + ZKAB001 | Carboplatin Etoposide ZKAB001 | 0 | 0 |
| ZKAB001 | ZKAB001 | 0 | 0 |